Australia's most trusted source of pharma news
Wednesday, 20 March 2019
News Headlines
Advertise in Pharma in Focus
Advertising in Pharma in Focus delivers you:
- Unique access to a $17 billion industry
- High visibility with over 11,500 readers every working day
- Great reaction with high click through rates
- Unparalled contact via unique beyond-the-click services
For more information, ring 02 9938 4381
Approvals Action
Cancer therapies added
ALL and breast cancer drugs approved.
ALL and breast cancer drugs approved.
Pipeline Monitor
Lilly aims I-O at lung cancer
Mid-year global filing plans for Cyramza to treat NSCLC.
Mid-year global filing plans for Cyramza to treat NSCLC.
Top of the Hill
Danger in 'affordability' play
Labor's focus on meds cost threatens sector unity.
Labor's focus on meds cost threatens sector unity.